Single-cell transcriptomic analysis reveals therapeutic mechanisms of adipose-derived stem cell exosomes in sepsis-induced lung injury
Open Access
- 2 July 2025
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9049-9064
Abstract
Background: Sepsis-induced acute lung injury remains a leading cause of mortality in critically ill patients, with limited effective treatments beyond supportive care. This study investigates the therapeutic efficacy and underlying mechanisms of adipose-derived stem cell (ADSC) exosomes on sepsis-induced lung injury and characterizes underlying cellular and molecular mechanisms. Methods: We employed a cecal ligation and puncture (CLP) mouse model of sepsis and using male C57BL/6J mice ( Mus musculus , 8–10 weeks old) and administered ADSC-derived exosomes intravenously. Animals were randomly assigned to Sham, CLP, or CLP + ADSC-exosome groups. Survival rates ( n =12 for each group) and lung histopathology ( n =5 for each group) were assessed. Single-cell RNA sequencing was performed on lung tissues to analyze cell type-specific transcriptomic changes and intercellular communication networks ( n =2 for each group). Results: ADSC exosome treatment significantly improved survival rates and reduced lung pathology in CLP mice. Treatment altered lung cellular composition, increasing neutrophils, NKT cells, and monocytes while decreasing B and T cells. Gene expression analysis revealed downregulation of pro-inflammatory markers (TNF, IL-10, CCL3, and CCL4) and upregulation of tissue repair pathways. In neutrophils, exosomes reduced expression of respiratory burst genes while enhancing tissue repair mechanisms. In monocytes, treatment suppressed inflammatory cytokine production while promoting anti-inflammatory phenotypes. Exosome treatment is associated with transcriptomic changes suggestive of restored intercellular communication networks disrupted by sepsis, with increased signaling via CSF3, ANGPT, SPP1, and CCL pathways. Conclusion: ADSC-derived exosomes effectively treat sepsis-induced lung injury by rebalancing the cellular environment and restoring homeostasis through modulation of immune cell function and intercellular communication, offering potential as a cell-free novel therapeutic approach for sepsis-related pulmonary complications.Keywords
This publication has 39 references indexed in Scilit:
- Immune suppressive activities of low-density neutrophils in sepsis and potential use as a novel biomarker of sepsis-induced immune suppressionScientific Reports, 2025
- CXCR4+ PD-L1+ neutrophils are increased in non-survived septic miceiScience, 2025
- Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsisNature Immunology, 2023
- Exosomes from adipose-derived mesenchymal stem cells alleviate sepsis-induced lung injury in mice by inhibiting the secretion of IL-27 in macrophagesCell Death Discovery, 2022
- Exosomes Derived from ADSCs Attenuate Sepsis-Induced Lung Injury by Delivery of Circ-Fryl and Regulation of the miR-490-3p/SIRT3 PathwayInflammation, 2021
- Understanding the role of neutrophils in acute respiratory distress syndromeBiomedical Journal, 2021
- The roles of macrophage polarization in the host immune response to sepsisInternational Immunopharmacology, 2021
- Sepsis and septic shockNature Reviews Disease Primers, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Fibroblasts regulate the switch from acute resolving to chronic persistent inflammationTrends in Immunology, 2001